Rare lephants
Screener

Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Nov 26, 2019 DEFA14A
8-K Nov 18, 2019 FORM 8-K
DEFA14A Nov 15, 2019 DEFA14A
DEFA14A Nov 12, 2019 DEFA14A
10-Q Nov 7, 2019 FORM 10-Q
8-K Nov 7, 2019 FORM 8-K
8-K Oct 17, 2019 FORM 8-K
DEF 14A Oct 15, 2019 DEF 14A
PRE 14A Oct 4, 2019 PRE 14A
4 Sep 24, 2019 OWNERSHIP DOCUMENT
3 Sep 24, 2019 OWNERSHIP DOCUMENT
8-K Sep 24, 2019 8-K
8-K Aug 30, 2019 FORM 8-K
8-K Aug 13, 2019 FORM 8-K
10-Q Aug 8, 2019 FORM 10-Q
8-K Aug 8, 2019 FORM 8-K
8-K Jul 29, 2019 8-K
8-K Jul 22, 2019 FORM 8-K
4 Jul 2, 2019 OWNERSHIP DOCUMENT
3 Jul 2, 2019 OWNERSHIP DOCUMENT
8-K Jun 17, 2019 FORM 8-K
8-K Jun 6, 2019 FORM 8-K
8-K May 31, 2019 FORM 8-K
8-K May 21, 2019 FORM 8-K
10-Q May 6, 2019 FORM 10-Q
← Newer Page 12 of 38 · 935 filings Older →